{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T13:29:58Z","timestamp":1786714198819,"version":"build-2736575974"},"reference-count":9,"publisher":"BMJ","issue":"8","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Rep"],"accepted":{"date-parts":[[2026,8,2]]},"published-print":{"date-parts":[[2026,8]]},"abstract":"<jats:p>A 70-year-old man with stage IV (extensive-stage) small cell lung carcinoma presented with progressive respiratory symptoms, refractory hypophosphataemia and hyponatraemia. The diagnostic evaluation revealed paraneoplastic arginine vasopressin-mediated syndrome of inappropriate diuresis and fibroblast growth factor 23-mediated renal phosphate wasting, consistent with tumour-induced osteomalacia. This report highlights the diagnostic complexity and reasoning required to identify dual paraneoplastic syndromes in an advanced malignancy, with emphasis on biochemical interpretation and integration of laboratory data.<\/jats:p>","DOI":"10.1136\/bcr-2025-269459","type":"journal-article","created":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T12:40:12Z","timestamp":1786711212000},"page":"e269459","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":0,"title":["Coexisting paraneoplastic SIAD and tumour-induced osteomalacia in stage IV small cell lung cancer: a diagnostic challenge"],"prefix":"10.1136","volume":"19","author":[{"ORCID":"https:\/\/orcid.org\/0009-0005-0456-2267","authenticated-orcid":false,"given":"Abdul","family":"Aziz","sequence":"first","affiliation":[{"name":"Good Hope Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3951-5867","authenticated-orcid":false,"given":"Nourhan","family":"Hassan","sequence":"additional","affiliation":[{"name":"Good Hope Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0006-3565-4401","authenticated-orcid":false,"given":"Mohammad Tahir Rafique","family":"Bhutta","sequence":"additional","affiliation":[{"name":"Good Hope Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arshad","family":"Jamil","sequence":"additional","affiliation":[{"name":"Respiratory, Sandwell and West Birmingham Hospitals NHS Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-6315-2471","authenticated-orcid":false,"given":"Reggie Sam","family":"John","sequence":"additional","affiliation":[{"name":"Good Hope Hospital, University Hospitals Birmingham NHS Foundation Trust, Birmingham, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"239","published-online":{"date-parts":[[2026,8,14]]},"reference":[{"key":"2026081405400762000_19.8.e269459.1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/s41572-020-00235-0","article-title":"Small-cell lung cancer","volume":"7","author":"Rudin","year":"2021","journal-title":"Nat Rev Dis Primers"},{"key":"2026081405400762000_19.8.e269459.2","doi-asserted-by":"publisher","DOI":"10.5306\/wjco.v5.i3.197"},{"key":"2026081405400762000_19.8.e269459.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.lungcan.2006.05.009"},{"key":"2026081405400762000_19.8.e269459.4","doi-asserted-by":"publisher","DOI":"10.1530\/ERC-11-0006"},{"key":"2026081405400762000_19.8.e269459.5","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1093\/ckj\/sfab078","article-title":"Hypophosphatemia in cancer patients","volume":"14","author":"Adhikari","year":"2021","journal-title":"Clin Kidney J"},{"key":"2026081405400762000_19.8.e269459.6","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/ndt\/gfad247","article-title":"Kidney phosphate wasting predicts poor outcome in polycystic kidney disease","volume":"39","author":"Xue","year":"2024","journal-title":"Nephrol Dial Transplant"},{"key":"2026081405400762000_19.8.e269459.7","doi-asserted-by":"crossref","first-page":"e3428","DOI":"10.1210\/clinem\/dgac253","article-title":"Tumor-induced Osteomalacia: A Systematic Review and Individual Patient\u2019s Data Analysis","volume":"107","author":"Rendina","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"2026081405400762000_19.8.e269459.8","doi-asserted-by":"publisher","DOI":"10.1177\/1066896915617828"},{"key":"2026081405400762000_19.8.e269459.9","doi-asserted-by":"crossref","DOI":"10.1007\/s00223-024-01317-x","article-title":"Treatment Advances in Tumor-Induced Osteomalacia","volume":"116","author":"Hartley","year":"2025","journal-title":"Calcif Tissue Int"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2025-269459","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T12:40:13Z","timestamp":1786711213000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2025-269459"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":9,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8,14]]},"published-print":{"date-parts":[[2026,8]]}},"alternative-id":["10.1136\/bcr-2025-269459"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2025-269459","relation":{},"ISSN":["1757-790X"],"issn-type":[{"value":"1757-790X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8]]}}}